Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 255 clinical trials
Modified Atkins Diet Versus Topiramate In Children With Epileptic Spasms Refractory To Hormonal Treatment: A Randomized Open-Label Study (TOPAMAD)

This study has been planned to compare the efficacy and tolerability of topiramate, a commonly used second line agent, with modified Atkins diet in children with epileptic spasms refractory to hormonal treatment, in a randomized open label study.

  • 0 views
  • 25 Jul, 2023
  • 1 location
Randomised Evaluation of COVID-19 Therapy

RECOVERY is a randomised trial investigating whether treatment with either Lopinavir-Ritonavir, Hydroxychloroquine, Corticosteroids, Azithromycin, Convalescent plasma or Tocilizumab prevents death in patients with COVID-19.

igiv
azithormycin
ritonavir
iv immunoglobulin
acute respiratory syndrome (sars)
  • 0 views
  • 05 Aug, 2020
Dual-target iTBS for Youth With ADHD

This study will employ accelerated intermittent theta burst stimulation (aiTBS) targeting two transcranial magnetic stimulation (TMS) sites: the right inferior frontal gyrus and left inferior parietal lobule.

  • 0 views
  • 24 Jul, 2025
Short Structured Psychological Intervention for Adults With ADHD - a Randomized Controlled Trial

The main objective is to evaluate whether SAINT will show better outcomes on measures of ADHD-related symptoms, everyday function, and quality-of-life measures, when compared to the self-help material, and if any possible differences in outcomes are related to better treatment adherence in SAINT.

stimulant
cns stimulants
substance use
attention deficit hyperactivity disorder
psychiatric symptoms
  • 0 views
  • 05 Aug, 2020
Changes in Brain Function Through Repeated Emotion Regulation Training

This information will be used to gain understanding of how repeated emotion regulation practices influence the brain and to develop a focused, tactic-based emotional regulation remediation approach for treatment of ADHD.

depressed mood
depressive symptoms
attention deficit hyperactivity disorder
psychotherapy
  • 0 views
  • 16 Feb, 2024
  • 1 location
Nigella Sativa in COVID-19

If encouraging outcomes occurred, NS supplementation may be recommended as an add-on to standard care protocol to enhance the recovery from COVID-19 disease in the current emerging situation.

pneumonia
SARS
antiviral drugs
PCR test
covid-19
  • 0 views
  • 01 Feb, 2023
  • 1 location
Doxapram Therapy in Preterm Infants (DOXA Trial)

Doxapram is a respiratory stimulant that has been administered off-label to treat AOP. Doxapram, as add-on treatment, seems to be effective in treating AOP and to prevent invasive mechanical ventilation. It is unclear if a preterm infant benefit from doxapram treatment on the longer term.

nervous
apnea
doxapram
off-label
mechanical ventilation
  • 0 views
  • 16 Feb, 2024
  • 18 locations
Cross-sectoral Collaboration in Multidisciplinary Treatment of Trauma-affected Refugees

The randomised controlled trial is comparing treatment as usual (TAU) comprising 10 sessions with a medical doctor (pharmacological treatment and psycho-education) and 16-21 sessions with a psychologist (manual-based cognitive behavioural therapy) with add-on of the social intervention. Overall, the intervention seeks to integrate working with social stressors alongside treatment for …

violence
cognitive therapy
stress disorders
depression
post-traumatic stress disorder
  • 0 views
  • 16 Feb, 2024
  • 1 location
PCBH With the Addition of Self-help CBT

This study is the first to step towards answering the question if the effects of brief intervention are large enough to merit large-scale implementation, and if an add-on of other brief and easily implemented treatments can increase them.

guided self-help
  • 0 views
  • 16 Feb, 2024
  • 2 locations
A Phase 2 Study to Evaluate Axatilimab for Hospitalized Patients With Respiratory Involvement Secondary to COVID-19

This is a randomized, double-blind, placebo-controlled, 29-day study to assess the efficacy and safety of axatilimab plus standard of care, compared with placebo plus standard of care, in patients with respiratory signs and symptoms secondary to novel coronavirus disease (COVID-19).

coronavirus infection
nasopharyngeal swab
coronavirus
SARS
covid-19
  • 0 views
  • 05 Aug, 2020